A new study finds that 35% of those taking Novartis semaglutide for treating obesity lost more than one-fifth of their total body weight, according to...
Some 94 oncology physicians, researchers, and leaders ask President Biden to nominate Janet Woodcock as FDA commissioner.
FDA approves a Regeneron Pharmaceuticals BLA for Evkeeza (evinacumab-dgnb) as an adjunct to other low-density lipoprotein cholesterol lowering therapi...
CDERs sixth annual drug safety report updates the Centers typical safety activities as well as those focused on the Covid-19 pandemic.
FDA clears an Acuitive Technologies 510(k) for its Citrefix Knotless Suture Anchor System with Citregen material technology, a bioresorbable synthetic...
Federal Register notice: FDA announces a 2/26 Vaccines and Related Biological Products Advisory Committee meeting to discuss a Janssen Biotech emergen...
Eye on FDA reports that the CDER Office of Prescription Drug Promotion continued its anemic enforcement level in 2020.
FDA issues Eli Lilly an emergency use authorization for bamlanivimab and etesevimab administered together for treating mild to moderate Covid-19 in ad...